Alembic Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Alembic Pharma	Caplin Point Lab	Jubilant Pharmova
Operational Metrics
Pharmaceuticals
US DMF Filings	149.0 .	n/a	98.0 .
Number of ANDA's Filed in Europe	21.0	n/a	38.0
Number of ANDA's Approved in Europe	19.0	n/a	37.0
Number of ANDA's Filed in Canada	21.0	n/a	24.0
Number of ANDA's Approved by Canada	20.0	n/a	24.0
Number of ANDA's Filed in Australia	17.0	n/a	n/a
Number of ANDA's Approved by Australia	14.0	n/a	n/a
Number of ANDA's Filed in South Africa	21.0	n/a	n/a
Number of ANDA's Approved by South Africa	7.0	n/a	n/a
Number of ANDA's Filed in Latam	14.0	n/a	n/a
Number of ANDA's Approved by Latam	4.0	n/a	n/a
Number of ANDA's Filed in USA	274.0 .	65.0 .	100.0 .
Number of ANDA's Approved By USFDA	235.0 .	59.0 .	62.0 .
R&D as a % of Total Sales	11.0 %	4.6 %	0.18 %
Financials
5 yr Average ROE	12.89 %	19.84 %	8.05 %
5yr average Equity Multiplier	1.39	1.15	1.96
5yr Average Asset Turnover Ratio	0.86	0.68	0.61
5yr Avg Net Profit Margin	11.15 %	25.35 %	6.45 %
Price to Book	2.61	4.29	2.44
P/E	21.93	23.97	37.23
5yr Avg Cash Conversion Cycle	9.46 Days	70.68 Days	-39.98 Days
Inventory Days	99.1 Days	66.07 Days	74.06 Days
Days Receivable	66.32 Days	110.7 Days	45.59 Days
Days Payable	164.9 Days	85.23 Days	149.89 Days
5yr Average Interest Coverage Ratio	30.59	633.04	3.78
5yr Avg ROCE	15.26 %	24.45 %	8.15 %
5yr Avg Operating Profit Margin	17.29 %	31.52 %	16.76 %
5 yr average Debt to Equity	0.14	0.0	0.55
5yr CAGR Net Profit	-12.64 %	17.23 %	0.08 %
5yr Average Return on Assets	9.32 %	17.23 %	4.12 %
Shareholdings
Promoter Holding	69.74 %	70.57 %	47.68 %
Share Pledged by Promoters	0.0	0.0	5.4 %
Change in Promoter Holding (3 Yrs)	0.13 %	-0.09 %	-3.0 %
Change in Mutual Fund Holding (3 Yrs)	1.71 %	1.45 %	7.63 %

Business

	Alembic Pharma	Caplin Point Lab	Jubilant Pharmova
Product Wise Break-Up	Product Wise Break-Up Formulations 85.93 Active Pharmaceutical Ingredient (API) 14.07 Branded Generic 0 Generic 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0	Product Wise Break-Up Life science chemicals 0 Allergy therapy products 0 Specialty intermediates 0 Branded Generics 25.0 Radiopharmaceuticals 0 Formulations 0 Active pharmaceutical ingredients 0 Formulations 75.0 Nutritional products 0 Solid dosage formulations 0 India Branded pharmaceuticals 0 0 0 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Life science chemicals 0 Anti-allergic 9.75 Specialty intermediates 0 Branded Generic 0 Radiopharmaceuticals 46.89 Formulations 0 Active Pharmaceutical Ingredient (API) 7.91 Generic 0 Nutritional products 0 Solid dosage formulations 8.71 India branded pharmaceuticals 0.7 Contract Research and Development Services 7.87 Contract Manufacturing 17.66 Active Pharmaceutical Ingredient (API) 0 Others 0.51
Product Wise Break-Up	Product Wise Break-Up Formulations 85.93 Active Pharmaceutical Ingredient (API) 14.07 Branded Generic 0 Generic 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0	Product Wise Break-Up Life science chemicals 0 Allergy therapy products 0 Specialty intermediates 0 Branded Generics 25.0 Radiopharmaceuticals 0 Formulations 0 Active pharmaceutical ingredients 0 Formulations 75.0 Nutritional products 0 Solid dosage formulations 0 India Branded pharmaceuticals 0 0 0 Active Pharmaceutical Ingredient (API) 0	Product Wise Break-Up Life science chemicals 0 Anti-allergic 9.75 Specialty intermediates 0 Branded Generic 0 Radiopharmaceuticals 46.89 Formulations 0 Active Pharmaceutical Ingredient (API) 7.91 Generic 0 Nutritional products 0 Solid dosage formulations 8.71 India branded pharmaceuticals 0.7 Contract Research and Development Services 7.87 Contract Manufacturing 17.66 Active Pharmaceutical Ingredient (API) 0 Others 0.51
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.76 India 39.24 USA 0 Africa 0 LATAM 0 China 0 Americas and Europe 0	Location Wise Break-Up Rest of the World 0 India 0 Latin America 76.0 Africa 6.0 Americas and Europe 0 China 0 USA 18.0	Location Wise Break-Up Rest of the World 5.89 India 2.76 LATAM 0 Africa 0 Americas and Europe 91.35 China 0 USA 0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Others 100	-	-

Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE